Publication: Factors associated with suboptimal adherence to antiretroviral therapy in Asia
Issued Date
2014-05-16
Resource Type
ISSN
17582652
Other identifier(s)
2-s2.0-84904893234
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the International AIDS Society. Vol.17, (2014)
Suggested Citation
Awachana Jiamsakul, Nagalingeswaran Kumarasamy, Rossana Ditangco, Patrick C.K. Li, Praphan Phanuphak, Thira Sirisanthana, Somnuek Sungkanuparph, Pacharee Kantipong, Christopher K.C. Lee, Mahiran Mustafa, Tuti Merati, Adeeba Kamarulzaman, Thida Singtoroj, Matthew Law Factors associated with suboptimal adherence to antiretroviral therapy in Asia. Journal of the International AIDS Society. Vol.17, (2014). doi:10.7448/IAS.17.1.18911 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/34245
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Factors associated with suboptimal adherence to antiretroviral therapy in Asia
Other Contributor(s)
The Kirby Institute
VHS Medical Centre India
Gokila
Queen Elizabeth Hospital Hong Kong
Chulalongkorn University
Chiang Mai University
Mahidol University
Chiangrai Prachanukroh Hospital
Hospital Sungai Buloh
Hospital Raja Perempuan Zainab II
Universitas Udayana
University of Malaya Medical Centre
amfAR - The Foundation for AIDS Research
VHS Medical Centre India
Gokila
Queen Elizabeth Hospital Hong Kong
Chulalongkorn University
Chiang Mai University
Mahidol University
Chiangrai Prachanukroh Hospital
Hospital Sungai Buloh
Hospital Raja Perempuan Zainab II
Universitas Udayana
University of Malaya Medical Centre
amfAR - The Foundation for AIDS Research
Abstract
Introduction: Adherence to antiretroviral therapy (ART) plays an important role in treatment outcomes. It is crucial to identify factors influencing adherence in order to optimize treatment responses. The aim of this study was to assess the rates of, and factors associated with, suboptimal adherence (SubAdh) in the first 24 months of ART in an Asian HIV cohort. Methods: As part of a prospective resistance monitoring study, the TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M) collected patients' adherence based on the World Health Organization-validated Adherence Visual Analogue Scale. SubAdh was defined in two ways: (i) <100% and (ii) <95%. Follow-up time started from ART initiation and was censored at 24 months, loss to follow-up, death, treatment switch, or treatment cessation for >14 days. Time was divided into four intervals: 0-6, 6-12, 12-18 and 18-24 months. Factors associated with SubAdh were analysed using generalized estimating equations. Results: Out of 1316 patients, 32% ever reported <100% adherence and 17% ever reported <95%. Defining the outcome as SubAdh <100%, the rates of SubAdh for the four time intervals were 26%, 17%, 12% and 10%. Sites with an average of >2 assessments per patient per year had an odds ratio (OR) = 0.7 (95% confidence interval (CI) (0.55 to 0.90), p = 0.006), compared to sites with ≤2 assessments per patient per year. Compared to heterosexual exposure, SubAdh was higher in injecting drug users (IDUs) (OR = 1.92, 95% CI (1.23 to 3.00), p = 0.004) and lower in homosexual exposure (OR = 0.52, 95% CI (0.38 to 0.71), p < 0.001). Patients taking a nucleoside transcriptase inhibitor and protease inhibitor (NRTI+PI) combination were less likely to report adherence <100% (OR = 0.36, 95% CI (0.20 to 0.67), p = 0.001) compared to patients taking an NRTI and non-nucleoside transcriptase inhibitor (NRTI+NNRTI) combination. SubAdh decreased with increasing time on ART (all p < 0.001). Similar associations were found with adherence <95% as the outcome. Conclusions: We found that SubAdh, defined as either <100% and <95%, was associated with mode of HIV exposure, ART regimen, time on ART and frequency of adherence measurement. The more frequently sites assessed patients, the lower the SubAdh, possibly reflecting site resourcing for patient counselling. Although social desirability bias could not be excluded, a greater emphasis on more frequent adherence counselling immediately following ART initiation and through the first six months may be valuable in promoting treatment and programme retention. © 2014 Jiamsakul A et al; licensee International AIDS Society.